Published Technical Disclosure Archive

Next-Gen Shrimp Immunity: Revolutionary Aquaculture Tech

Publication ID: 24-11856971_0005_PTD
Published: October 26, 2025
Category:Future Evolutions & Paradigm Shifts

Legal Citation

pr1or.art Inc., “Next-Gen Shrimp Immunity: Revolutionary Aquaculture Tech,” Published Technical Disclosure No. 24-11856971_0005_PTD, Published October 26, 2025, available at https://archive.pr1or.art/24-11856971_0005_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,856,971.

Background and Problem Solved

The original patent, 'Method for improving immunity in shrimps', demonstrated the effectiveness of cocoa rind extracts in enhancing immunity. However, the method had limitations, such as the need for manual administration and the lack of targeted disease resistance. The present invention addresses these limitations by introducing paradigm-shifting approaches to immunity enhancement, including vaccine-based, feed-based, bioreactor-based, personalized, and nano-formulation-based solutions.

Novelty and Inventive Step

The new claims introduce multiple novel elements, including the use of micro-encapsulation, engineered antimicrobial peptides, bioreactor design, genotyping-based personalization, and nano-formulation. These innovations overcome the limitations of the original patent, providing a non-obvious and significant advancement in the field.

Alternative Embodiments and Variations

Other potential implementations of the invention could include alternative delivery mechanisms, such as implantable devices or aerosol administration, as well as the integration of machine learning algorithms to optimize treatment regimens. Additionally, the use of different types of extracts or bioactive compounds could be explored to further expand the invention's scope.

Potential Commercial Applications and Market

The next-generation immunity enhancement systems disclosed herein have significant commercial potential in the aquaculture industry, with potential applications in disease prevention, reduced antibiotic use, and improved animal welfare. The market for these innovations is substantial, with the global aquaculture market projected to reach USD 245 billion by 2027.

CPC Classifications

SectionClassGroup
A A23 A23K50/80
A A23 A23K10/30
A A61 A61D7/00
A A01 A01K2207/20
A A01 A01K2207/25
A A01 A01K2227/70

Field of Art

Aquaculture biotechnology, specifically shrimp immunity enhancement and bioactive extract processing, involving microbiology, marine biology, and pharmaceutical formulation techniques

Person of Ordinary Skill (PHOSITA) Profile

A professional with advanced degree in marine biotechnology or aquaculture science, familiar with immunological techniques, extract preparation methods, and crustacean disease management strategies

Obviousness Rationale

A person skilled in the art would recognize that the source patent's cocoa rind extract method naturally invites technological extensions using standard bioengineering approaches. The PTD's variations represent predictable improvements using well-established techniques in drug delivery, genetic analysis, and nanoscale formulation. These modifications would be considered routine optimization by an expert familiar with shrimp immunology and extract processing technologies.

Obvious Combinations & Variations

Source Patent Element
Extract administration method using aqueous ethanol extraction
PTD Variation
Micro-encapsulated controlled-release vaccine delivery system
Obviousness Reasoning
Controlled drug delivery is a known technique in pharmaceutical sciences, and adapting the extraction method to micro-encapsulation would be an obvious design choice for improving extract stability and targeted release
Source Patent Element
Cocoa rind extract for shrimp immunity enhancement
PTD Variation
Engineered antimicrobial peptides derived from cocoa rind extract
Obviousness Reasoning
Protein engineering and peptide modification are standard techniques in biotechnology, and identifying specific immune-boosting peptides would be a predictable extension of the original extract's immunological properties
Source Patent Element
Oral and injection-based administration methods
PTD Variation
Nano-formulation for enhanced bioavailability and reduced dosage
Obviousness Reasoning
Nanotechnology for drug delivery is a well-established approach in pharmaceutical sciences, and improving extract absorption represents a logical optimization of the original administration techniques
Source Patent Element
General immunity enhancement method
PTD Variation
Genotyping-based personalized immunity treatment
Obviousness Reasoning
Personalized medicine approaches using genetic markers are increasingly common, and applying genetic screening to shrimp immunity represents an obvious technological progression
Source Patent Element
Extract preparation from cocoa rind
PTD Variation
Specialized bioreactor design for large-scale extract production
Obviousness Reasoning
Scaling and optimizing biological production processes is a standard engineering practice, and developing more efficient extraction methods would be an expected innovation by a skilled practitioner
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11856971 and the disclosed technological variations, a person having ordinary skill in the art would find the claimed innovations obvious and lacking inventive step. The systematic extensions of cocoa rind extract administration techniques through micro-encapsulation, nano-formulation, genetic personalization, and engineered peptide approaches represent predictable technological progressions that do not meet the non-obviousness requirements of patent protection.

Original Patent Information

Patent NumberUS 11,856,971
TitleMethod for improving immunity in shrimps
Assignee(s)NATIONAL PINGTUNG UNIVERSITY OF SCIENCE & TECHNOLOGY